|
⚲
|
| Keyboard |
| Augustine Lawlor | |
|---|---|
| Firm | |
| Address | 47 Thorndike Street, Suite B11 Cambridge, MA 02141 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Leap Therapeutics Inc | 021-475708 | Executive Officer | 77.2 M of 77.2 M |
||
| Layerbio Inc | 021-404810 | Director | 0.1 M of 1.0 M |
||
| PainReform Ltd | 021-392928 | Director | 6.0 M of 6.0 M |
||
| Leap Therapeutics Inc | 021-299736 | Executive Officer | 18.0 M of 18.0 M |
||
| Vaxinnate Corp | 021-248311 | Director | 3.2 M of 4.3 M |
||
| Catalyst Biosciences Inc | 021-241558 | Director | 1.9 M of 2.0 M |
||
| GITR Inc | 021-239513 | Executive Officer | 1.5 M of 18.5 M |
||
| Catalyst Biosciences Inc | 021-233381 | Director | 3.2 M of 5.0 M |
||
| Vaxinnate Corp | 021-225706 | Director | 6.0 M of 6.3 M |
||
| Catalyst Biosciences Inc | 021-216115 | Director | 5.0 M of 5.0 M |
||
| Globeimmune Inc | 021-213450 | Director | 0.4 M of 0.4 M |
||
| Globeimmune Inc | 021-211908 | Director | 7.5 M of 7.5 M |
||
| Mosaic Biosciences Inc | 021-211595 | Director | 2.3 M of 2.3 M |
||
| Nanomr Inc | 021-208520 | Director | 2.4 M of 2.4 M |
||
| Catalyst Biosciences Inc | 021-201639 | Director | 0.4 M of 0.8 M |
||
| Nanomr Inc | 021-199233 | Director | 2.6 M of 2.6 M |
||
| Catalyst Biosciences Inc | 021-184613 | Director | 13.4 M of 18.6 M |
||
| Stemgent Inc | 021-182570 | Director | 11.3 M of 11.3 M |
||
| Stemgent Inc | 021-172717 | Director | 6.3 M of 8.8 M |
||
| GITR Inc | 021-171111 | Executive Officer | 3.2 M of 6.5 M |
||
| Stemgent Inc | 021-167970 | Director | 0.6 M of 0.6 M |
||
| Tensha Therapeutics Inc | 021-164058 | Director | 0.5 M of 15.0 M |
||
| Apofore Corp | 021-163739 | Director | 0.5 M of 10.0 M |
||
| Pathogenetix Inc | 021-163699 | Director | 11.5 M of 11.5 M |
||
| Nanomr Inc | 021-163349 | Director | 11.4 M of 17.9 M |
||
| Mosaic Biosciences Inc | 021-163239 | Director | 1.0 M of 1.0 M |
||
| Cardiovascular Systems Inc | 021-160699 | Director | 0.0 M | ||
| Stemgent Inc | 021-158280 | Director | 0.8 M of 3.0 M |
||
| Dekkun Corp | 021-153226 | Director | 9.9 M of 30.5 M |
||
| Cardiovascular Systems Inc | 021-151810 | Director | 13.5 M of 13.5 M |
||
| Cardiovascular Systems Inc | 021-151811 | Director | 3.5 M of 3.5 M |
||
| Pathogenetix Inc | 021-149968 | Director | 1.5 M of 1.8 M |
||
| Pathogenetix Inc | 021-149969 | Director | 0.9 M of 1.2 M |
||
| Anexon Inc | 021-149305 | Director | 3.0 M of 3.0 M |
||
| Anexon Inc | 021-149306 | Director | 2.0 M of 2.0 M |
||
| Shape Pharmaceuticals Inc | 021-148863 | Director | 1.0 M of 4.5 M |
||
| Shape Pharmaceuticals Inc | 021-148861 | Director | 2.0 M of 2.0 M |
||
| Stemgent Inc | 021-141981 | Director | 10.6 M of 14.1 M |
||
| US Genomics Inc | 021-55322 | Director | 1.0 M of 2.0 M |
||
| Stemgent Inc | 021-115615 | Director | 2.7 M of 3.0 M |
||
| Vaxinnate Corp | 021-43952 | Director | 24.8 M of 25.0 M |
||
| Globeimmune Inc | 021-56316 | Director | 18.0 M of 18.0 M |
||
| Catalyst Biosciences Inc | 021-60286 | Director | 40.4 M of 40.4 M |
||
| HCV Management VIII LLC | |||||
| Healthcare Ventures IX LP | 021-141176 | Director | of 250.0 M |
||